HbA1c (%) (461 studies, 97 interventions) |
E + EB + SS + G |
−1.42 [−2.02 −0.82] (−2.28, −0.57) |
0.98 |
0% |
E + MT + EB |
−0.78 [−1.00, −0.57] (−1.43, −0.14) |
0.87 |
71% |
E + G + R |
−0.91 [−1.80, −0.01] (−1.99, 0.18) |
0.83 |
0% |
E + MT + P + G |
−0.82 [−1.46, −0.18] (−1.71, 0.06) |
0.83 |
54% |
MT + AB + R |
−0.89 [−1.73, −0.04] (−1.93, 0.16) |
0.83 |
0% |
E + AB + SS + P |
−1.02 [−2.29, 0.25] (−2.43, 0.39) |
0.81 |
0% |
E + SS + G |
−0.69 [−1.04, −0.35] (−1.39, 0.00) |
0.81 |
96% |
MT + R |
−0.84 [−1.66, −0.02] (−1.86, 0.18) |
0.81 |
0% |
Common within-network between-study variance τ2 = 0.09, Ι2 = 86.5% |
Design-by-treatment interaction model for inconsistency X2 (d.f., p-value, τ2): 154.58 (128, 0.05, 0.32) |
BMI (kg/m2) (230 studies, 76 interventions) |
E + AB + EB + SS |
−1.88 [−2.89, −0.88] (−3.26, −0.51) |
0.93 |
100% |
E + MT + P + G |
−1.70 [−3.03, −0.37] (−3.33, −0.07) |
0.90 |
100% |
E + MT + EB + SS + G |
−2.40 [−5.34, 0.54] (−5.50, 0.70) |
0.89 |
100% |
E + MT + AB + EB + R |
−1.28 [−1.88, −0.68] (−2.39, −0.16) |
0.87 |
88% |
E + SD |
−2.10 [−4.90, 0.70] (−5.07, 0.87) |
0.86 |
100% |
E + MT + AB + SD + P |
−1.83 [−4.40, 0.74] (−4.58, 0.92) |
0.84 |
76% |
E + SS + G |
−1.08 [−1.94, −0.22] (−2.35, 0.19) |
0.82 |
100% |
AB + EB |
−2.80 [−8.43, 2.83] (−8.54, 2.94) |
0.80 |
100% |
Common within-network between-study variance τ2 = 0.22, Ι2 = 61.1% |
Design-by-treatment interaction model for inconsistency X2 (d.f., p-value, τ2): 86.19 (64, 0.03, 0.44) |
LDL cholesterol (mg/dL) (171 studies, 58 interventions) |
E + MT + SS + P |
−35.10 [−42.35, −27.84] (−42.75, −27.44) |
1 |
0% |
E + MT + SS + R |
−16.63 [−21.72, −11.54] (−22.24, −11.03) |
0.95 |
0% |
E + AB + SD |
−15.47 [−25.71, −5.23] (−26.05, −4.89) |
0.92 |
100% |
E + MT + AB + SS + R |
−14.99 [−27.66, −2.32] (−27.98, −2.01) |
0.89 |
0% |
E + AB + EB + P |
−11.44 [−14.58, −8.30] (−15.32, −7.57) |
0.88 |
88% |
E + MT + G |
−16.70 [−34.60, 1.20] (−34.91, 1.51) |
0.88 |
100% |
E + EB + SS + G |
−11.93 [−19.74, −4.12] (−20.13, −3.73) |
0.87 |
0% |
E + R |
−10.50 [−17.66, −3.33] (−18.07, −2.92) |
0.84 |
0% |
E + MT + AB + SD |
−8.77 [−11.05, −6.49] (−11.98, −5.56) |
0.82 |
100% |
Common within-network between-study variance τ2 = 1.27, Ι2 = 70.8% |
Design-by-treatment interaction model for inconsistency X2 (d.f., p-value, τ2): 104.97 (46, <0.001, 2.07) |